Untreated sleep apnea is a risk factor for hypertension, and CPAP treatment effects a blood
pressure reduction comparable to that of pharmacologic monotherapy. Nevertheless, many …

Background: Sleep disordered breathing (SDB) is common in severe chronic heart failure
(CHF) and is associated with increased morbidity and mortality. The prevalence of SDB in …

We present a review of the English-language literature from 1972 through 2000 pertaining to
systemic high BP in patients with sleep-disordered breathing (SDB). We reviewed studies …

The relationship between CHF and SDB is likely to be bidirectional, CHF impacting on SDB
severity and vice versa. Identification of SDB in the CHF population appears to be important …

Breathing‐related sleep disorders, particularly obstructive sleep apnea, have been largely
undiagnosed in people with cardiovascular disease, probably due to limited health care …

Emerging research highlights the complex interrelationships between sleep-disordered
breathing and cardiovascular disease, presenting clinical and research opportunities as well …

Sleep-related breathing disorders are highly prevalent in patients with established
cardiovascular disease. Obstructive sleep apnea (OSA) affects an estimated 15 million adult …

Purpose Nocturnal cardiac conduction abnormalities are commonly observed in patients
with sleep-disordered breathing (SDB). However, few population-based studies have …

Sleep-related breathing disorders, including obstructive sleep apnea (OSA) and central
sleep apnea (CSA), have a major impact on cardiovascular function. It has shown an …

Sleep-disordered breathing (SDB) is common in the general population. More than five
apneas and/or hypopneas per hour of sleep (apnea–hypopnea index, AHI) were identified …